Phosphorylated p-tau immunoassays p-tau181 [5] and p-tau217 [6] confirmed that plasma p-tau has high sensitivity and specificity to detect AD neuropathology, which was ascertained with [18F]flortaucipir PET [7,8]. This evidence concerns the gene MAPT and Alzheimer disease.